NasdaqGM - Delayed Quote • USD
Avidity Biosciences, Inc. (RNA)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 7:45 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 415,500 | 10 |
| Sales | 331,402 | 12 |
| Net Shares Purchased (Sold) | 84,098 | 22 |
| Total Insider Shares Held | 5.11M | -- |
| % Net Shares Purchased (Sold) | 1.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEVIN ARTHUR A Director | Sale at price 27.11 per share. | Indirect | 542,214 | Apr 3, 2024 |
| BOYCE SARAH Chief Executive Officer | Sale at price 26.25 per share. | Direct | 734,919 | Apr 2, 2024 |
| BOYCE SARAH Chief Executive Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 34,720 | Apr 2, 2024 |
| LEVIN ARTHUR A Director | Sale at price 23.97 per share. | Direct | 119,848 | Mar 19, 2024 |
| LEVIN ARTHUR A Director | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 6,200 | Mar 19, 2024 |
| MACLEAN MICHAEL F Chief Financial Officer | Sale at price 24.52 per share. | Direct | 980,760 | Mar 13, 2024 |
| MACLEAN MICHAEL F Chief Financial Officer | Conversion of Exercise of derivative security at price 8.82 per share. | Direct | 352,800 | Mar 13, 2024 |
| LEVIN ARTHUR A Director | Sale at price 22.00 - 22.04 per share. | Direct | 609,017 | Mar 12, 2024 |
| LEVIN ARTHUR A Director | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 31,000 | Mar 12, 2024 |
| BOYCE SARAH Chief Executive Officer | Sale at price 21.39 - 22.63 per share. | Direct | 2,430,392 | Mar 12, 2024 |
| BOYCE SARAH Chief Executive Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 138,880 | Mar 12, 2024 |
| BOYCE SARAH Chief Executive Officer | Sale at price 20.13 per share. | Direct | 1,691,306 | Mar 1, 2024 |
| BOYCE SARAH Chief Executive Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 104,160 | Mar 1, 2024 |
| LEVIN ARTHUR A Director | Sale at price 10.13 per share. | Direct | 18,832 | Jan 22, 2024 |
| MACLEAN MICHAEL F Chief Financial Officer | Sale at price 10.13 per share. | Direct | 16,370 | Jan 22, 2024 |
| BOYCE SARAH Chief Executive Officer | Sale at price 10.13 per share. | Direct | 51,582 | Jan 22, 2024 |
| FLANAGAN W MICHAEL PH.D. Chief Technology Officer | Sale at price 10.13 per share. | Direct | 41,827 | Jan 22, 2024 |
| MCCARTHY TERESA Officer | Sale at price 10.13 per share. | Direct | 20,918 | Jan 22, 2024 |
| MACLEAN MICHAEL F Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| BOYCE SARAH Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| FLANAGAN W MICHAEL PH.D. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| MCCARTHY TERESA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| LEVIN ARTHUR A Director | Sale at price 22.01 per share. | Direct | 2,201 | Mar 15, 2023 |
| LEVIN ARTHUR A Director | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 124 | Mar 15, 2023 |
| LEVIN ARTHUR A Officer | Sale at price 23.62 - 24.24 per share. | Direct | 236,567 | Feb 14, 2023 |
| LEVIN ARTHUR A Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 12,400 | Feb 14, 2023 |
| BOYCE SARAH Chief Executive Officer | Sale at price 24.26 - 24.36 per share. | Direct | 1,217,727 | Feb 3, 2023 |
| BOYCE SARAH Chief Executive Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 62,000 | Feb 3, 2023 |
| LEVIN ARTHUR A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 20, 2023 |
| MACLEAN MICHAEL F Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 20, 2023 |
| BOYCE SARAH Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 20, 2023 |
| FLANAGAN W MICHAEL PH.D. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 20, 2023 |
| MCCARTHY TERESA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 20, 2023 |
| LEVIN ARTHUR A Officer | Sale at price 22.00 per share. | Direct | 220,028 | Jan 12, 2023 |
| LEVIN ARTHUR A Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 12,400 | Jan 12, 2023 |
| LEVIN ARTHUR A Officer | Sale at price 22.01 per share. | Direct | 880,568 | Dec 29, 2022 |
| LEVIN ARTHUR A Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 49,600 | Dec 29, 2022 |
| BOYCE SARAH Chief Executive Officer | Sale at price 22.80 - 23.07 per share. | Direct | 1,141,614 | Aug 25, 2022 |
| BOYCE SARAH Chief Executive Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 61,876 | Aug 25, 2022 |
| LEVIN ARTHUR A Officer | Sale at price 22.00 - 22.12 per share. | Direct | 1,767,666 | Aug 16, 2022 |
| LEVIN ARTHUR A Officer | Conversion of Exercise of derivative security at price 0.53 - 1.24 per share. | Direct | 69,562 | Aug 16, 2022 |
| BOYCE SARAH Chief Executive Officer | Sale at price 22.47 per share. | Direct | 2,247 | Aug 15, 2022 |
| BOYCE SARAH Chief Executive Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 124 | Aug 15, 2022 |
| LEVIN ARTHUR A Officer | Sale at price 27.89 per share. | Direct | 697,218 | Nov 18, 2021 |
| LEVIN ARTHUR A Officer | Conversion of Exercise of derivative security at price 0.53 - 1.24 per share. | Direct | 30,571 | Nov 18, 2021 |
| RTW INVESTMENTS, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 18.00 per share. | Indirect | 14,400,000 | Aug 4, 2021 |
| LEVIN ARTHUR A Officer | Sale at price 27.75 - 29.14 per share. | Direct | 568,074 | Jun 25, 2021 |
| LEVIN ARTHUR A Officer | Conversion of Exercise of derivative security at price 0.53 - 1.24 per share. | Direct | 22,859 | Jun 25, 2021 |
| LEVIN ARTHUR A Officer | Sale at price 27.75 per share. | Direct | 5,550 | Jun 17, 2021 |
| LEVIN ARTHUR A Officer | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 248 | Jun 17, 2021 |
Related Tickers
DYN Dyne Therapeutics, Inc.
23.86
+0.89%
KURA Kura Oncology, Inc.
17.53
-0.85%
ARQT Arcutis Biotherapeutics, Inc.
9.10
-3.70%
SANA Sana Biotechnology, Inc.
7.61
-1.55%
ETNB 89bio, Inc.
9.08
+2.25%
RGNX REGENXBIO Inc.
15.69
-2.61%
PASG Passage Bio, Inc.
1.1500
-4.17%
FDMT 4D Molecular Therapeutics, Inc.
25.25
+1.90%
IMVT Immunovant, Inc.
28.22
-0.35%
XENE Xenon Pharmaceuticals Inc.
39.88
-1.07%